| abstract |
Oral composition comprising Berberis aristata with a minimum titre of 50% in berberine chloride, Cynara Scolimus extract with a minimum titre of 2.5% in caffeoylquinic acids, a polyoxyethylenate sorbitan ester, Piper nigrum extract with a minimum titre of 80% in pipeline content. This oral composition in particular in the form of a nutraceutical formulation is in particular suitable for the treatment of the metabolic syndrome. |